Molecular characterisation of the extracellular matrix protein 1 gene in lipoid proteinosis in South Africa

DSpace/Manakin Repository

Show simple item record

dc.contributor.author van Hougenhouck-Tulleken, George
dc.contributor.author Wesley
dc.date.accessioned 2006-11-20T10:15:41Z
dc.date.available 2006-11-20T10:15:41Z
dc.date.issued 2006-11-20T10:15:41Z
dc.identifier.uri http://hdl.handle.net/10539/1908
dc.description Faculty of Health Science Degree of Master of Science in Human Genetics 9809684w en
dc.description.abstract Lipoid proteinosis (LP) (OMIM 247100) is a rare autosomal recessive disorder that is caused by mutations within the extracellular matrix protein 1 gene (ECM1). The ECM1 gene has been shown to play a role in angiogenesis and connective tissue matrix generation, especially in skin and bone. The role of ECM1 in normal skin development and maintenance is further highlighted by its role in LP and in lichen sclerosis where autoantibodies are raised against ECM1. LP usually presents in the first year of life with a faint or hoarse cry and is due to a hyaline-like material deposited in the mucous membranes of the vocal cords. Gradually (over years) there is diffuse skin infiltration and general skin thickening with a yellow, waxy appearance. There is excessive scarring with scars often appearing at sites of minor injury or stress. In many cases, the eyelids show typical beaded papules. In some cases, calcification of certain aspects of the temporal lobes have been observed, and may or may not be associated with variable neurological, psychiatric and neuropsychological sequelae. Although the prevalence of LP in South Africa is unknown, the disproportionately high number of case reports originating from South Africa indicates that LP is unusually common in certain South African populations, most notably the Coloured population of Namaqualand and the Afrikaans-speaking White population. This may be due to a possible LP founder effect that occurred early during the European colonisation of South Africa. The founder effect was investigated in the South African LP patients by conducting ECM1 mutation and linked marker analysis. The data supported a LP founder effect as the Q276X mutation in exon seven of ECM1 was present in the homozygous state in all LP patients investigated. In addition, the Q276X mutation was associated with a single founder haplotype of 19-12-23-22 (ND1-D1S2343-D1S305-D1S2624). These markers were in significant linkage disequilibrium with each other and with the Q276X mutation. VI As variation within ECM1 may alter properties of skin such as healing and scar formation, ECM1 exons two through five and the first part of exon six were investigated for nucleotide variation using denaturing high performance liquid chromatography (dHPLC) and direct DNA sequencing in three different South African populations. Eight nucleotide variants were identified, of which six were cytosine to thymine transitions. Seven of the eight variants identified were either intronic or synonymous, with one variant being a missense variant, changing a methionine residue to a threonine residue (T130M). en
dc.format.extent 2278871 bytes
dc.format.mimetype application/pdf
dc.language.iso en en
dc.subject Lipoid proteinosis en
dc.subject matrix en
dc.subject disorder en
dc.subject skin en
dc.subject scars en
dc.title Molecular characterisation of the extracellular matrix protein 1 gene in lipoid proteinosis in South Africa en
dc.type Thesis en


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search WIReDSpace


Advanced Search

Browse

My Account

Statistics